Deregulation of collagen metabolism in human stomach cancer

Pathobiology

Volumn 71, Issue 6, 2004, Pages 308-313

  Guszczyn, Tomasz ^a   Sobolewski, Krzysztof ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

1 integrin; Collagen; Gelatinases; Prolidase; Stomach cancer

Indexed keywords

BETA1 INTEGRIN; GELATINASE A; GELATINASE B; HYDROXYPROLINE; PROLINE DIPEPTIDASE;

ARTICLE; COLLAGEN DEGRADATION; COLLAGEN METABOLISM; COLORIMETRY; CONTROLLED STUDY; DEREGULATION; ENZYME ACTIVITY; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN SYNTHESIS; STATISTICAL SIGNIFICANCE; STOMACH CANCER; WESTERN BLOTTING; ZYMOGRAPHY;

ANTIGENS, CD29; BLOTTING, WESTERN; CARCINOMA; COLLAGEN; DIPEPTIDASES; ELECTROPHORESIS, POLYACRYLAMIDE GEL; GASTRIC MUCOSA; HUMANS; HYDROXYPROLINE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; STOMACH NEOPLASMS;

EID: 11444267454     PISSN: 10152008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000081726     Document Type: Article

References (42)

1. Gillessen A, Voss B, Rauterberg J, Domschke W: Distribution of collagen types I, III, and IV in peptic ulcer and normal gastric mucosa in man. Scand J Gastroenterol 1993;28:688-689.
2. Kondou S, Kanayama K, Morise K: Immunohistochemical study of collagen in gastric cancer tissue. Nihon Rinsho Meneki Gakkai Kaishi 1995;18:168-177.
3. Bornstein P, Sage H: Regulation of collagen gene expression. Prog Nucleic Acid Res Mol Biol 1989;37:67-106.
4. Kurita A, Kikuchi S, Kakita A: Immunohistochemical study of collagen synthesis in an in-vitro model of scirrhous carcinoma of the stomach. Hepatogastroenterology 2002;49:1235-1238.
5. David L, Nesland JM, Holm R, Sobrinho-Simoes M: Expression of laminin, collagen IV, fibronectin, and type IV collagenase in gastric carcinoma. An immunohistochemical study of 87 patients. Cancer 1994;73:518-527.
6. Slack JL, Parker MI, Robinson VR, Bornstein P: Regulation of collagen I gene expression by ras. Mol Cell Biol 1992;12:4714-4723.
7. Matsui H, Kubochi K, Shimada A, Hasumi A: Desmoplastic response in scirrhous gastric carcinoma: Imbalance between collagen synthesis and degradation. Anticancer Res 2000;20:4733-4738.
8. Matsui H, Kubochi K, Okazaki I, Yoshino K, Ishibiki K, Kitajima M: Collagen biosynthesis in gastric cancer: Immunohistochemical analysis of propyl 4-hydroxylase. J Surg Oncol 1999;70:239-246.
9. Tahara E: Growth factors and oncogenes in human gastrointestinal carcinomas. J Cancer Res Clin Oncol 1990;116:121-131.
10. Bolon I, Gouyer V, Devouassoux M, Vandenbunder B, Wernert N, Moro D, Brambilla C, Brambilla E: Expression of c-ets-1, collagenase 1, and urokinase-type plasminogen activator genes in lung carcinomas. Am J Pathol 1995;147:1298-1310.
11. Naito Y, Kino I: Pathogenesis and progression of scirrhous carcinoma. Gan To Kagaku Ryoho 1994;21:2364-2370.
12. Matsuoka T, Yashiro M, Nishimura S, Inoue T, Fujihara T, Sawada T, Kato Y, Seki S, Hirakawa YS, Chung K: Increased expression of alpha2beta1-integrin in the peritoneal dissemination of human gastric carcinoma. Int J Mol Med 2000;5:21-25.
13. Carey DJ: Control of growth and differentiation of vascular cells by extracellular matrix. Ann Rev Physiol 1991;53:161-177.
14. Ruoslahti E: Control of cell motility and tumor invasion by extracellular matrix interaction. Br J Cancer 1992;66:239-242.
15. Albelda SM, Buck CA: Integrins and other cell adhesion molecules. FASEB J 1990;4:2868-2880.
16. Bosco M, Chan C, Matsuura N, Takada Y, Zetter BR, Hemler ME: In vitro and in vivo consequences of VLA-2 expression on rhabdomyosarcoma cells. Science 1991;251:1600-1602.
17. 1 integrins in tumor. Cancer Biol 1993;4:277-283.
18. Stamenkovic I: Extracellular matrix remodelling: The role of matrix metalloproteinases. J Pathol 2003;200:448-464.
19. Myara I, Charpentier C, Lemonnier A: Prolidase and prolidase deficiency. Life Sci 1984;34:1985-1998.
20. Yaron A, Naider F: Proline-dependent structural and biological properties of peptides and proteins. Crit Rev Biochem Mol Biol 1993;28:31-81.
21. Emmerson KS, Phang JM: Hydrolysis of proline dipeptides completely fulfills the proline requirement in a proline - Auxotropic Chinese Hamster Ovary cell line. J Nutr 1993;123:909-914.
22. Pałka JA, Phang JM: Prolidase activity in fibroblasts is regulated by interaction of extracellular matrix with cell surface integrin receptors. J Cell Biochem 1997;67:166-175.
23. Myara I, Charpentier C, Lemonnier A: Optimal conditions for prolidase assay by proline colorimetric determination: Application to imidodipeptiduria. Clin Chim Acta 1982;125:193-205.
24. Chinard FP: Photometric estimation of proline and ornithine. J Biol Chem 1952;199:91-95.
25. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (London) 1970;227:680-685.
26. Unemori EN, Werb Z: Reorganization of polymerized actin: A possible trigger for induction of procollagenase in fibroblasts cultured in and on collagen gels. J Cell Biol 1986;103:1021-1031.
27. Lowry OH, Rosenbrough NI, Far AL, Randall IR: Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265-275.
28. Woessner JF Jr: Determination of hydroxyproline in connective tissue; in Hall DA (ed): The Methodology of Connective Tissue Research. Oxford, Joynson-Bruvvers, 1976, pp 227-233.
29. Bańkowski E, Rzeczycki W, Nowak H, Jodczyk K: Decrease of collagen biosynthesis ability of rat kidney fibroblasts transformed with SV-40 virus. Mol Cell Biochem 1978;20:77-83.
30. Karna E, Surazyński A, Pałka JA: Collagen metabolism disturbances are accompanied by an increase in prolidase activity in lung carcinoma planoepitheliale. Int J Exp Path 2000;81:341-347.
31. Pałka JA, Surazyński A, Karna E, Orłowski K, Puchalski Z, Pruszyński K, Laszkiewicz J, Dzienis H: Prolidase activity dysregulation in chronic pancreatitis and pancreatic cancer. Hepatogastroenterology 2002;49:1699-1703.
32. Chamson A, Voigtlander V, Myara I, Frey J: Collagen biosynthetic anomalies in prolidase deficiency: Effect of glycyl-L-proline on the degradation of newly synthesized collagen. Clin Physiol Biochem 1989;7:128-136.
33. 4 administration inducing liver cytolysis and fibrosis in rat. Br J Exp Path 1987;68:7-13.
34. Galewska Z, Romanowicz L, Bańkowski E, Jaworski S: Preeclampsia-associated decrease of potential collagenolytic and gelatinolytic activities in the wall of the umbilical cord vein. Int J Biochem Cell Biol 2002;34:24-32.
35. Miltyk W, Karna E, Pałka JA: Inhibition of prolidase activity by non-steroid antiinflammatory drugs in cultured human skin fibroblasts. Pol J Pharmacol 1996;48:609-613.
36. Pałka JA, Miltyk W, Karna E, Wołczyński S: Modulation of prolidase activity during in vitro aging of human skin fibroblasts the role of extracellular matrix collagen. Tokai J Exp Clin Med 1996;21:207-213.
37. Pałka JA, Karna E, Miltyk W: Fibroblast chemotaxis and prolidase activity modulation by insulin-like growth factor II and mannose 6-phosphate. Mol Cell Biochem 1997;168:177-183.
38. Yoon SO, Park SJ, Yun CH, Chung AS: Roles of matrix metalloproteinases in tumor metastasis and angiogenesis. J Biochem Mol Biol 2003;36:128-137.
39. Kleiner DE, Stetler-Stevenson WG: Matrix metalloproteinases and metastasis. Cancer Chemother Pharmac 1999;43:S42-S51.
40. Liotta LA, Rao CN: Role of the extracellular matrix in cancer. Ann NY Acad Sci 1985;460:333-344.
41. Sunada H, Nagai Y: Mechanism of collagen degradation by collagenase: A transition process of the collagen molecule from collagenase substrate to gelatinase substrate. Biomed Res 1983;4:61-69.
42. Nakajima M, Chop AM: Tumor invasion and extracellular matrix degradative enzymes: Regulation of activity by organ factors. Semin Cancer Biol 1991;2:115-127.